TRICARE policy for at-home COVID testing

Starting January 15, 2022, private health insurers must cover the cost of eight at-home COVID-19 tests per month. However, this policy will not apply to TRICARE. Beneficiaries must still have a prescription indicating a medical necessity for the test for the beneficiary to be reimbursed. If a beneficiary buys an at-home test without a prescription, TRICARE will not cover it.

Learn more

Resource for free at-home COVID-19 testing

First oral treatment, Paxlovid, authorized for emergency use

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for Paxlovid for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients over 12. Paxlovid is covered for TRICARE beneficiaries if ordered by a provider.

Learn more

COVID-19 vaccine information

Get clinical resources for COVID-19 vaccination, including distribution and administration, the storage and handling of, reporting and education for each separate vaccine.

Get the latest

TRICARE expands coverage of investigational drugs

Effective September 30, 2020, TRICARE has expanded coverage for the use of investigational drugs to treat serious or life-threatening cases of COVID-19 infection or its associated sequelae.

Learn more

TRICARE covers certain COVID clinical trials

Effective October 30, 2020, clinical trials sponsored by or in collaboration with the National Institute of Allergy and Infectious Disease (NIAID) will be covered for the treatment and prevention of COVID-19.

Learn more

Telemedicine and COVID-19 provider information

Providers can familiarize themselves on the TRICARE telemedicine benefit, including claims, codes and ABA details.

Learn more

Temporary telehealth ACD code change

TRICARE is announcing an exception to policy regarding the use of Telehealth (TH) capabilities for ABA services during the COVID-19 pandemic.

Learn more

TRICARE temporarily revises telemedicine benefit

To improve virtual healthcare access during COVID-19, TRICARE has temporarily revised its telemedicine policy.

Learn more

COVID-19 Convalescent Plasma (CCP)

The Defense Health Agency (DHA) is leading an effort to collect 10,000 units of CCP by September 30, 2020

Learn more

New guidance on telemedicine Intensive Outpatient Programs (IOP) and half-day Partial Hospitalization Programs (PHP)

The Defense Health Agency (DHA) has issued new guidance on the use of telemedicine

Learn more

Referral and authorization dates extended 180 days

In an effort to reduce administrative burden for providers, we have automatically extended certain outpatient referrals and authorizations.

Learn more

Elective procedures are postponed 60 days

The Department of Defense (DOD) is directing all military hospitals/clinics and DTFs to immediately postpone all elective surgeries until May 31.

Learn more